M4MM

Cybin Secures Additional U.S. Patent for CYB003

LOS ANGELES- Cybin Inc. a biopharmaceutical company, announced the granting of U.S. patent 12,291,499 by the United States Patent and Trademark Office. This patent pertains to pharmaceutical compositions and oral dosage forms within the company's ...

NEW: Comprehensive List of Cannabis Events in 2025

LOS ANGELES - The cannabis industry is alive with opportunity and collaboration in 2025. These events serve as critical platforms for education, networking, and driving business success. Whether you're a veteran in the industry or ...

Week In Review: Cronos Expands Medical Cannabis Presence in Switzerland; Cybin Secures Up to US $500 Million via Convertible Debentures to Fuel Clinical Growth; iAnthus Reports Unanimous Approval at Annual General Meeting; Mike Tyson Urges Trump to Act on Cannabis Reform

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...

Cybin Secures Additional U.S. Patent for CYB003

LOS ANGELES- Cybin Inc. a biopharmaceutical company, announced the granting of U.S. patent 12,291,499 by the United States Patent and Trademark Office. This patent pertains to pharmaceutical compositions and oral dosage forms within the company's ...

Flora Growth Completes Acquisition of JustCBD

MIAMI & TORONTO--Flora Growth Corp. (NASDAQ: FLGC), a outdoor cultivator and manufacturer of global cannabis products and brands, announced today that it has acquired 100% of the equity interests in each of Just Brands LLC ...

Colombia Cannabis Market “Economic Impact Assessment”

BOGOTA, Colombia - CannabCo Pharmaceutical Corp. Colombia S.A.S. (CannabCo Colombia), a Colombia based cannabis cultivator and manufacturer of medical cannabis products, is pleased to announce the completion of an Economic Impact Assessment for its operations ...

Subscribe To Our Newsletter